Tagged with Australian Centre for Cancer Glycomics

For the entire month of May, and highlighting Mother’s Day, Griffith University’s Institute for Glycomics is partnering with local Gold Coast florists to raise funds and awareness to support vital research into cancers that affect women. “The Mum’s the Word Mother’s Day campaign invites the local community to ‘thank her a bunch’ by gifting the […]

A community partnership between Griffith University’s Institute for Glycomics and Sanctuary Cove precinct has raised $31,299 during Breast Cancer Awareness Month to aid vital breast cancer research. A series of pink-themed events and promotions across the month of October were hosted by the Sanctuary Cove precinct to raise funds and awareness for the devastating disease, […]

Griffith University’s Institute for Glycomics is joining forces with the Sanctuary Cove precinct this October in a community partnership to raise funds to support vital breast cancer research. The Institute for Glycomics is home to the Australian Centre for Cancer Glycomics (A2CG), a unique national resource dedicated to cancer glycomics research. “Our unique research approach […]

Griffith University’s Institute for Glycomics has been awarded a Medical Research grant of $100,000 from The Ian Potter Foundation to support their project ‘Pioneering Tissue Microdissection Glycomics for Better Patient Outcomes’. This grant will enable the acquisition of a Laser Capture Microdissection system (LCM). This new piece of equipment will be integrated into the Institute’s […]

Research into the development of an early detection test for ovarian cancer at Griffith University’s Institute for Glycomics has been given a $300,000 funding boost from The Bourne Foundation and a further significant funding pledge from Tour de Cure. “Despite decades of research, there is currently no easily accessible, non-invasive and reliable early detection test […]

A multi-million dollar investment by Griffith University to establish a world leading cancer research centre is now challenging traditional approaches to cancer testing and treatments.